SEC Form 4 · accession 0001567619-18-004784
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M Desmarais
Director · 10% Owner
Period of report
Oct 29, 2018
Accepted (ET)
Oct 30, 2018 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 493,398 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF5 | $1.23 | Oct 29, 2018 | A | 75,000 | A | — | Oct 29, 2028 | Common Stock | 75,000 | 75,000 | D |
| OptionF1 | $4.40 | holding | — | — | — | — | Dec 1, 2025 | Common Stock | 15,000 | 15,000 | D |
| Warrant | $4.00 | holding | — | — | — | Dec 17, 2015 | Nov 17, 2020 | Common Stock | 125,000 | 125,000 | D |
| Warrant | $4.00 | holding | — | — | — | Mar 18, 2016 | Mar 18, 2021 | Common Stock | 250,000 | 250,000 | D |
| Warrant | $4.00 | holding | — | — | — | Mar 18, 2016 | Dec 31, 2018 | Common Stock | 444,444 | 444,444 | D |
| Warrant | $4.00 | holding | — | — | — | Mar 18, 2016 | Dec 31, 2018 | Common Stock | 400,000 | 400,000 | D |
| OptionF2 | $3.73 | holding | — | — | — | — | Jun 10, 2026 | Common Stock | 35,000 | 35,000 | D |
| WarrantF3 | $4.00 | holding | — | — | — | Jun 30, 2016 | Jun 30, 2021 | Common Stock | 40,000 | 40,000 | I |
| Warrant | $4.00 | holding | — | — | — | Sep 26, 2016 | Sep 26, 2021 | Common Stock | 80,000 | 80,000 | D |
| Warrant | $4.00 | holding | — | — | — | Feb 10, 2017 | Feb 10, 2022 | Common Stock | 21,731 | 21,731 | D |
| Warrant | $4.00 | holding | — | — | — | Mar 1, 2017 | Mar 1, 2022 | Common Stock | 16,667 | 16,667 | D |
| Stock OptionF4 | $3.35 | holding | — | — | — | — | Jun 23, 2027 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1The option vests to the extent of 5,000 shares on each of December 1, 2016, 2017 and 2018.
- F2The option vests to the extent of 11,667 shares on each of June 10, 2016 and June 10, 2017, and 11,666 shares on June 10, 2018.
- F3The warrant is held by a trust established by the Reporting Person for the benefit of his immediate family. The Reporting Person serves as a trustee of the trust.
- F4The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019.
- F5The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020.